HGF and early-onset autosomal dominant Alzheimer disease: It has been reported that HGF-induced Met activation exerts beneficial neuroprotective effects in preclinical models of cerebral ischaemia, spinal cord injuries and neurological pathologies, such as Alzheimer’s disease, amyotrophic lateral sclerosis and multiple sclerosis35.